Gemina Laboratories (XCNQ:GLAB) Ending Cash Position : C$0.00 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Ending Cash Position?

Gemina Laboratories's Ending Cash Position for the quarter that ended in Jan. 2024 was C$0.00 Mil.

Gemina Laboratories's quarterly Ending Cash Position declined from Jul. 2023 (C$0.12 Mil) to Oct. 2023 (C$0.00 Mil) and declined from Oct. 2023 (C$0.00 Mil) to Jan. 2024 (C$0.00 Mil).

Gemina Laboratories's annual Ending Cash Position declined from Jan. 2022 (C$1.16 Mil) to Jan. 2023 (C$0.08 Mil) and declined from Jan. 2023 (C$0.08 Mil) to Jan. 2024 (C$0.00 Mil).

Gemina Laboratories Ending Cash Position Historical Data

The historical data trend for Gemina Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Ending Cash Position Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Ending Cash Position

1.16

0.08

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Ending Cash Position	Get a 7-Day Free Trial							0.08	1.06	0.12	-	-

Gemina Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Gemina Laboratories's Ending Cash Position for the fiscal year that ended in Jan. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.083	+	-0.082
	=	0.00

Gemina Laboratories's Ending Cash Position for the quarter that ended in Jan. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.003	+	-0.002
	=	0.00

Gemina Laboratories Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

GLABF:USA 8I7:Germany

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Executives

James Damian Tansey

Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines